Virtual Worlds for Real Life: New Hope in Modern Medicine & Surgery?
summary
Dassault Systèmes builds physics‑based virtual twins of organs and patients, claims to power 65% of last year’s FDA‑approved drugs, and shows concrete wins: a CNS program skips primate studies after virtual brain and spine diffusion models, a trial design cuts enrollment by 20 patients (about $1.6M) using a synthetic control arm, and a five‑year FDA collaboration uses a living heart model plus generative AI to reproduce valve repair trial outcomes in silico, published jointly and used to plan real surgeries.
AI-written summary · about
chapters (11)
- 0:00Virtual twin tech in medicine
- 0:36Why virtual twins matter
- 1:58Car crash tests to virtual bodies
- 2:39Healthcare challenges & change
- 4:46Virtual twins in life sciences
- 7:56Drug delivery to spine
- 9:19Synthetic control arms in trials
- 12:31Synthetic treatment arms for devices
- 16:50Personalized virtual twins for monitoring
- 18:35Summary & future of virtual twins
- 20:02Q&A on German apps
related talks
30mHospitals of the future
28mReducing barriers to healthcare training with real-time 3D
47mDesigning Reality: How Immersive Technologies Are Shaping the Future of Human Experience
31mTransforming communities with RT3D programs
28mVirtual Reality as a Practical Instrument
47mImagining a better world through the power of the metaverse
24mThe future of AR, VR and Mixed Reality
47mKeynote: How VR, AR, MR and XR are changing the world